- Works count
- 281
- Citation count
- 17,218
- H-index
- 46
- i10-index
- 105
Research interests
Publications
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine · 2016 · 10.1056/nejmoa1606038
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
New England Journal of Medicine · 2015 · 10.1056/nejmoa1505654
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70440-1
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Leukemia · 2011 · 10.1038/leu.2011.196
International uniform response criteria for multiple myeloma
Leukemia · 2006 · 10.1038/sj.leu.2404284
Current projects
No projects listed.